Does RIBOCICLIB Cause Hospitalisation? 30 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 30 reports of Hospitalisation have been filed in association with RIBOCICLIB (KISQALI). This represents 0.1% of all adverse event reports for RIBOCICLIB.
30
Reports of Hospitalisation with RIBOCICLIB
0.1%
of all RIBOCICLIB reports
0
Deaths
25
Hospitalizations
How Dangerous Is Hospitalisation From RIBOCICLIB?
Of the 30 reports, 25 (83.3%) required hospitalization.
Is Hospitalisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIBOCICLIB. However, 30 reports have been filed with the FAERS database.
What Other Side Effects Does RIBOCICLIB Cause?
Neutropenia (3,585)
Nausea (3,404)
Fatigue (3,327)
Malignant neoplasm progression (2,468)
Death (2,452)
Vomiting (1,953)
Diarrhoea (1,830)
White blood cell count decreased (1,683)
Pain (1,637)
Metastases to bone (1,538)
What Other Drugs Cause Hospitalisation?
CLOZAPINE (12,144)
CINACALCET (6,997)
DARBEPOETIN ALFA (5,682)
MACITENTAN (3,414)
APIXABAN (3,315)
ADALIMUMAB (3,033)
DUPILUMAB (2,529)
LENALIDOMIDE (2,241)
DENOSUMAB (2,076)
PALIPERIDONE (2,066)
Which RIBOCICLIB Alternatives Have Lower Hospitalisation Risk?
RIBOCICLIB vs RIBOFLAVIN
RIBOCICLIB vs RIBOFLAVIN 5'-PHOSPHATE
RIBOCICLIB vs RIBOFLAVIN 5^-PHOSPHATE
RIBOCICLIB vs RIFABUTIN
RIBOCICLIB vs RIFAMPICIN